BACKGROUND Portal venous thromboembolism caused by malignant pancreatic neuroendocrine tumor metastasis,as the initial presentation of portal hypertension and upper gastrointestinal bleeding,is a rare entity.To our kn...BACKGROUND Portal venous thromboembolism caused by malignant pancreatic neuroendocrine tumor metastasis,as the initial presentation of portal hypertension and upper gastrointestinal bleeding,is a rare entity.To our knowledge,there are no reports of this entity in pregnant women.We describe a case of pancreatic neuroendocrine carcinoma during pregnancy with hematemesis and hematochezia as the initial presentation and review the literature to analyze the demographic,clinical,and pathological features to provide a reference for clinical diagnosis and treatment.CASE SUMMARY A 40-year-old woman presented with hematemesis and hematochezia at 26-wk gestation;she had no other remarkable medical history.The physical examination revealed normal vital signs,an anemic appearance,and lower abdominal distension.Abdominal color Doppler ultrasonography showed portal vein thrombosis,splenomegaly,intrauterine pregnancy,and intrauterine fetal death.Esophagogastroduodenoscopy revealed esophageal and gastric varicose veins and portal hypertensive gastropathy.Contrast-enhanced computed tomography demonstrated multiple emboli formation in the portal and splenic veins,multiple round shadows in the liver with a slightly lower density,portal vein broadening,varicose veins in the lower esophagus and gastric fundus,splenomegaly,bilateral pleural effusion,ascites and pelvic effusion,broadening of the common bile duct,and increased uterine volume.According to the results of Positron emission tomography-computed tomography and immunohistochemical staining,the final diagnoses were that the primary lesion was a pancreatic neuroendocrine tumor and that there were secondary intrahepatic metastases and venous cancer thrombogenesis.CONCLUSION Upper gastrointestinal bleeding in a pregnant woman may be caused by portal hypertension due to a malignant pancreatic neuroendocrine tumor.展开更多
BACKGROUND To evaluate the clinicopathological features and prognosis of gastric cancer(GC)occurring synchronously with gastrointestinal stromal tumor(GIST).CASE SUMMARY We report 19 patients with concurrent GC and GI...BACKGROUND To evaluate the clinicopathological features and prognosis of gastric cancer(GC)occurring synchronously with gastrointestinal stromal tumor(GIST).CASE SUMMARY We report 19 patients with concurrent GC and GIST(17 male and 2 female,median age 62 years).GC was most often located in the lower third of the stomach.GIST was diagnosed preoperatively in four patients.GIST was most often located in the gastric body(n=8,42%).The most common growth pattern in GIST was extraluminal(n=12,63%).The positive expression rates of CD117 and CD34 in GIST were 100% and 95%,respectively.Most patients with GIST(n=17,89%)were very low or low risk.There was no recurrence of GIST during follow-up.The 3-year cumulative survival rate was 73.9%,and the 5-year cumulative survival rate was 59.2%.The combined analysis of this study and literature reports(47 reports,157 patients)found that GC and GIST were usually located in the lower third(42%)and middle third(51%)of the stomach.GC was usually early(stage I:42%),poorly differentiated(42%)intestinal-type adenocarcinoma(51%).GISTs were primarily small in diameter(median:1.2 cm)and very low or low risk(89%).CONCLUSION Synchronous GC and GIST may not be rare.They have specific clinicopathological characteristics,and may have mutual inhibition in pathogenesis and progression.展开更多
Carbohydrates have a protein sparing effect,but long-term feeding of a high-carbohydrate diet(HCD)leads to metabolic disorders due to the limited utilization efficiency of carbohydrates in fish.How to mitigate the neg...Carbohydrates have a protein sparing effect,but long-term feeding of a high-carbohydrate diet(HCD)leads to metabolic disorders due to the limited utilization efficiency of carbohydrates in fish.How to mitigate the negative effects induced by HCD is crucial for the rapid development of aquaculture.Uridine is a pyrimidine nucleoside that plays a vital role in regulating lipid and glucose metabolism,but whether uridine can alleviate metabolic syndromes induced by HCD remains unknown.In this study,a total of480 Nile tilapia(Oreochromis niloticus)(average initial weight 5.02±0.03 g)were fed with 4 diets,including a control diet(CON),HCD,HCD+500 mg/kg uridine(HCUL)and HCD+5,000 mg/kg uridine(HCUH),for 8 weeks.The results showed that addition of uridine decreased hepatic lipid,serum glucose,triglyceride and cholesterol(P<0.05).Further analysis indicated that higher concentration of uridine activated the sirtuin1(sirt1)/adenosine 5-monophosphate-activated protein kinase(AMPK)signaling pathway to increase lipid catabolism and glycolysis while decreasing lipogenesis(P<0.05).Besides,uridine increased the activity of glycogen synthesis-related enzymes(P<0.05).This study suggested that uridine could alleviate HCD-induced metabolic syndrome by activating the sirt1/AMPK signaling pathway and promoting glycogen synthesis.This finding reveals the function of uridine in fish metabolism and facilitates the development of new additives in aquatic feeds.展开更多
文摘BACKGROUND Portal venous thromboembolism caused by malignant pancreatic neuroendocrine tumor metastasis,as the initial presentation of portal hypertension and upper gastrointestinal bleeding,is a rare entity.To our knowledge,there are no reports of this entity in pregnant women.We describe a case of pancreatic neuroendocrine carcinoma during pregnancy with hematemesis and hematochezia as the initial presentation and review the literature to analyze the demographic,clinical,and pathological features to provide a reference for clinical diagnosis and treatment.CASE SUMMARY A 40-year-old woman presented with hematemesis and hematochezia at 26-wk gestation;she had no other remarkable medical history.The physical examination revealed normal vital signs,an anemic appearance,and lower abdominal distension.Abdominal color Doppler ultrasonography showed portal vein thrombosis,splenomegaly,intrauterine pregnancy,and intrauterine fetal death.Esophagogastroduodenoscopy revealed esophageal and gastric varicose veins and portal hypertensive gastropathy.Contrast-enhanced computed tomography demonstrated multiple emboli formation in the portal and splenic veins,multiple round shadows in the liver with a slightly lower density,portal vein broadening,varicose veins in the lower esophagus and gastric fundus,splenomegaly,bilateral pleural effusion,ascites and pelvic effusion,broadening of the common bile duct,and increased uterine volume.According to the results of Positron emission tomography-computed tomography and immunohistochemical staining,the final diagnoses were that the primary lesion was a pancreatic neuroendocrine tumor and that there were secondary intrahepatic metastases and venous cancer thrombogenesis.CONCLUSION Upper gastrointestinal bleeding in a pregnant woman may be caused by portal hypertension due to a malignant pancreatic neuroendocrine tumor.
文摘BACKGROUND To evaluate the clinicopathological features and prognosis of gastric cancer(GC)occurring synchronously with gastrointestinal stromal tumor(GIST).CASE SUMMARY We report 19 patients with concurrent GC and GIST(17 male and 2 female,median age 62 years).GC was most often located in the lower third of the stomach.GIST was diagnosed preoperatively in four patients.GIST was most often located in the gastric body(n=8,42%).The most common growth pattern in GIST was extraluminal(n=12,63%).The positive expression rates of CD117 and CD34 in GIST were 100% and 95%,respectively.Most patients with GIST(n=17,89%)were very low or low risk.There was no recurrence of GIST during follow-up.The 3-year cumulative survival rate was 73.9%,and the 5-year cumulative survival rate was 59.2%.The combined analysis of this study and literature reports(47 reports,157 patients)found that GC and GIST were usually located in the lower third(42%)and middle third(51%)of the stomach.GC was usually early(stage I:42%),poorly differentiated(42%)intestinal-type adenocarcinoma(51%).GISTs were primarily small in diameter(median:1.2 cm)and very low or low risk(89%).CONCLUSION Synchronous GC and GIST may not be rare.They have specific clinicopathological characteristics,and may have mutual inhibition in pathogenesis and progression.
基金financial support provided by the National Key Research and Development Program(grant number:2022YFD2400800)National Natural Science Foundation of China(grant number:31972798)。
文摘Carbohydrates have a protein sparing effect,but long-term feeding of a high-carbohydrate diet(HCD)leads to metabolic disorders due to the limited utilization efficiency of carbohydrates in fish.How to mitigate the negative effects induced by HCD is crucial for the rapid development of aquaculture.Uridine is a pyrimidine nucleoside that plays a vital role in regulating lipid and glucose metabolism,but whether uridine can alleviate metabolic syndromes induced by HCD remains unknown.In this study,a total of480 Nile tilapia(Oreochromis niloticus)(average initial weight 5.02±0.03 g)were fed with 4 diets,including a control diet(CON),HCD,HCD+500 mg/kg uridine(HCUL)and HCD+5,000 mg/kg uridine(HCUH),for 8 weeks.The results showed that addition of uridine decreased hepatic lipid,serum glucose,triglyceride and cholesterol(P<0.05).Further analysis indicated that higher concentration of uridine activated the sirtuin1(sirt1)/adenosine 5-monophosphate-activated protein kinase(AMPK)signaling pathway to increase lipid catabolism and glycolysis while decreasing lipogenesis(P<0.05).Besides,uridine increased the activity of glycogen synthesis-related enzymes(P<0.05).This study suggested that uridine could alleviate HCD-induced metabolic syndrome by activating the sirt1/AMPK signaling pathway and promoting glycogen synthesis.This finding reveals the function of uridine in fish metabolism and facilitates the development of new additives in aquatic feeds.
